Literature DB >> 8834875

The anti-human immunodeficiency virus agent 3'-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells.

R Sundseth1, S S Joyner, J T Moore, R E Dornsife, I K Dev.   

Abstract

Patients infected with the human immunodeficiency virus experienced severe hematopoietic toxicity after treatment with the deoxynucleoside analog 3'-fluorothymidine (FLT). Using several methods for the analysis of genome integrity, including histochemical staining of the 3' ends of DNA and both conventional and pulsed-field agarose gel electrophoresis, we demonstrated that FLT caused extensive DNA fragmentation in CEM cells that was not observed when these cells were treated with other, less toxic thymidine analogs. In addition, a distinctive pattern of small DNA fragments that is characteristic of cells in the process of programmed cell death was observed in the genomic DNA of CEM cells treated with FLT. We conclude that FLT induces DNA fragmentation and apoptosis in a human cell line of hematopoietic origin, and we offer this observation as a possible explanation for the severe toxicity of FLT observed in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834875      PMCID: PMC163111     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis.

Authors:  J L Martin; C E Brown; N Matthews-Davis; J E Reardon
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

2.  Apoptosis. The role of the endonuclease.

Authors:  M J Arends; R G Morris; A H Wyllie
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  A simple technique for quantitation of low levels of DNA damage in individual cells.

Authors:  N P Singh; M T McCoy; R R Tice; E L Schneider
Journal:  Exp Cell Res       Date:  1988-03       Impact factor: 3.905

4.  Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.

Authors:  S H Kaufmann
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

5.  Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine.

Authors:  E Matthes; C Lehmann; D Scholz; H A Rosenthal; P Langen
Journal:  Biochem Biophys Res Commun       Date:  1988-06-16       Impact factor: 3.575

6.  Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.

Authors:  R E Dornsife; M H St Clair; A T Huang; T J Panella; G W Koszalka; C L Burns; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

7.  Hydroxyurea increases the phosphorylation of 3'-fluorothymidine and 3'-azidothymidine in CEM cells.

Authors:  A Karlsson; P Reichard; F Eckstein
Journal:  Eur J Biochem       Date:  1989-12-22

8.  Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.

Authors:  C H Chen; M Vazquez-Padua; Y C Cheng
Journal:  Mol Pharmacol       Date:  1991-05       Impact factor: 4.436

9.  Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine.

Authors:  C H Chen; Y C Cheng
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

10.  Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event.

Authors:  P Huang; W Plunkett
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more
  9 in total

1.  Is 3'-deoxy-3'-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?

Authors:  Sven N Reske; Sandra Deisenhofer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

2.  Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT.

Authors:  Joseph J Grudzinski; John M Floberg; Sarah R Mudd; Justin J Jeffery; Eric T Peterson; Alice Nomura; Ronald R Burnette; Wolfgang A Tomé; Jamey P Weichert; Robert Jeraj
Journal:  Phys Med Biol       Date:  2012-03-07       Impact factor: 3.609

3.  Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long-term non-progressors.

Authors:  S Moretti; S Marcellini; A Boschini; G Famularo; G Santini; E Alesse; S M Steinberg; M G Cifone; G Kroemer; C De Simone
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  Synthesis and Biological Evaluation of 5'-O-Fatty Acyl Ester Derivatives of 3'-Fluoro-2',3'-dideoxythymidine as Potential Anti-HIV Microbicides.

Authors:  Hitesh K Agarwal; Bhupender S Chhikara; Guofeng Ye; Sitaram Bhavaraju; Ajay Dixit; Anil Kumar; Gustavo F Doncel; Keykavous Parang
Journal:  Molecules       Date:  2022-05-23       Impact factor: 4.927

5.  Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

Authors:  Neale S Mason; Brian J Lopresti; James Ruszkiewicz; Xinxin Dong; Sonali Joyce; George Leef; Malabika Sen; Abdus S Wahed; Chester A Mathis; Jennifer R Grandis; Sufi M Thomas
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

6.  NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.

Authors:  Alexander M Spence; Mark Muzi; Jeanne M Link; John M Hoffman; Janet F Eary; Kenneth A Krohn
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

7.  Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug.

Authors:  Ana C Venhoff; Dirk Lebrecht; Frank U Reuss; Brigitte Heckl-Ostreicher; Roland Wehr; Ulrich A Walker; Nils Venhoff
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

8.  Premature and accelerated aging: HIV or HAART?

Authors:  Reuben L Smith; Richard de Boer; Stanley Brul; Yelena Budovskaya; Hans van Spek
Journal:  Front Genet       Date:  2013-01-28       Impact factor: 4.599

9.  [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study.

Authors:  W G E Direcks; S C Berndsen; N Proost; G J Peters; J Balzarini; M D Spreeuwenberg; A A Lammertsma; C F M Molthoff
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.